Table of Content

1 Industry Overview

• 1.1 Central Nervous System (CNS) Biomarkers Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Central Nervous System (CNS) Biomarkers
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Central Nervous System (CNS) Biomarkers Market by Type

• 3.1 By Type
  • 3.1.1 Biomarker of Exposure
  • 3.1.2 Biomarker of Effect
  • 3.1.3 Biomarker of Susceptibility
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

• 4.1 AbaStar MDX (Company Profile, Sales Data etc.)
• 4.2 Apitope International (Company Profile, Sales Data etc.)
• 4.3 ExonHit Therapeutics (Company Profile, Sales Data etc.)
• 4.4 Metabolon Inc. (Company Profile, Sales Data etc.)
• 4.5 Myriad RBM (Company Profile, Sales Data etc.)
• 4.6 OPKO Health (Company Profile, Sales Data etc.)
• 4.7 Osta Biotechnologies (Company Profile, Sales Data etc.)
• 4.8 Proteome Sciences (Company Profile, Sales Data etc.)
• 4.9 Thermo Fisher Scientific (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Market Demand

• 6.1 Demand Situation
  • 6.1.1 Demand in Research
  • 6.1.2 Demand in Medical Use
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Central Nervous System (CNS) Biomarkers

Table Application Segment of Central Nervous System (CNS) Biomarkers

Table Global Central Nervous System (CNS) Biomarkers Market 2013-2024, by Application, in USD Million

Table Major Company List of Biomarker of Exposure

Table Major Company List of Biomarker of Effect

Table Major Company List of Biomarker of Susceptibility

Table Global Central Nervous System (CNS) Biomarkers Market 2013-2018, by Type, in USD Million

Table Global Central Nervous System (CNS) Biomarkers Market Forecast 2019-2024, by Type, in USD Million

Table AbaStar MDX Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of AbaStar MDX (Sales Revenue, Cost, Gross Margin)

Table Apitope International Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of Apitope International (Sales Revenue, Cost, Gross Margin)

Table ExonHit Therapeutics Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of ExonHit Therapeutics (Sales Revenue, Cost, Gross Margin)

Table Metabolon Inc. Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of Metabolon Inc. (Sales Revenue, Cost, Gross Margin)

Table Myriad RBM Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of Myriad RBM (Sales Revenue, Cost, Gross Margin)

Table OPKO Health Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of OPKO Health (Sales Revenue, Cost, Gross Margin)

Table Osta Biotechnologies Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of Osta Biotechnologies (Sales Revenue, Cost, Gross Margin)

Table Proteome Sciences Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of Proteome Sciences (Sales Revenue, Cost, Gross Margin)

Table Thermo Fisher Scientific Overview List

Table Central Nervous System (CNS) Biomarkers Business Operation of Thermo Fisher Scientific (Sales Revenue, Cost, Gross Margin)

Table Global Central Nervous System (CNS) Biomarkers Sales Revenue 2013-2018, by Company, in USD Million

Table Global Central Nervous System (CNS) Biomarkers Sales Revenue Share, by Company, in USD Million

Table Central Nervous System (CNS) Biomarkers Demand in Research, 2013-2018, in USD Million

Table Major Consumers in Research

Table Central Nervous System (CNS) Biomarkers Demand in Medical Use, 2013-2018, in USD Million

Table Major Consumers in Medical Use

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Central Nervous System (CNS) Biomarkers Demand Forecast 2019-2024, by Application, in USD Million

Table Central Nervous System (CNS) Biomarkers Production 2013-2018, by Region, in USD Million

Table Global Central Nervous System (CNS) Biomarkers Market 2013-2018, by Region, in USD Million

Table Global Central Nervous System (CNS) Biomarkers Market Share 2013-2018, by Region, in USD Million

Table North America Central Nervous System (CNS) Biomarkers Market Size 2013-2018, by Country, in USD Million

Table Europe Central Nervous System (CNS) Biomarkers Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Central Nervous System (CNS) Biomarkers Market Size 2013-2018, by Country, in USD Million

Table South America Central Nervous System (CNS) Biomarkers Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Central Nervous System (CNS) Biomarkers Market Size 2013-2018, by Country, in USD Million

Table Central Nervous System (CNS) Biomarkers Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

List of Figures

Figure Central Nervous System (CNS) Biomarkers Industry Chain Structure

Figure Global Central Nervous System (CNS) Biomarkers Market Growth 2013-2018, by Type, in USD Million

Figure North America Central Nervous System (CNS) Biomarkers Market, by Company, in 2018

Figure Europe Central Nervous System (CNS) Biomarkers Market Market, by Company, in 2018

Figure Asia-Pacific Central Nervous System (CNS) Biomarkers Market Market, by Company, in 2018

Figure South America Central Nervous System (CNS) Biomarkers Market Market, by Company, in 2018

Figure Middle East & Africa Central Nervous System (CNS) Biomarkers Market Market, by Company, in 2018

Figure North America Central Nervous System (CNS) Biomarkers Market Size and Growth 2013-2018, in USD Million

Figure Europe Central Nervous System (CNS) Biomarkers Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Central Nervous System (CNS) Biomarkers Market Size and Growth 2013-2018, in USD Million

Figure South America Central Nervous System (CNS) Biomarkers Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Central Nervous System (CNS) Biomarkers Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview

Snapshot
The global Central Nervous System (CNS) Biomarkers market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Central Nervous System (CNS) Biomarkers by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Biomarker of Exposure
Biomarker of Effect
Biomarker of Susceptibility
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
AbaStar MDX
Apitope International
ExonHit Therapeutics
Metabolon Inc.
Myriad RBM
OPKO Health
Osta Biotechnologies
Proteome Sciences
Thermo Fisher Scientific
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Research
Medical Use
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)